.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

TARKA Drug Profile

« Back to Dashboard
Tarka is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers.

The generic ingredient in TARKA is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.

Summary for Tradename: TARKA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Formulation / Manufacturing:see details
Drug Prices: :see details
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996RXNo► subscribe► subscribe
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 1996RXYes► subscribe► subscribe
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TARKA

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 19964,933,361► subscribe
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 19965,721,244► subscribe
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 19964,933,361► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: TARKA

Drugname Dosage Strength RLD Submissiondate
trandolapril and verapamil hydrochlorideExtended-release Tablets1 mg/240 mgTarka2/20/2008
trandolapril and verapamil hydrochlorideExtended-release Tablets2 mg/180 mg and 2 mg/240 mgTarka11/9/2007
trandolapril and verapamil hydrochlorideExtended-release Tablets4 mg/ 240 mgTarka7/24/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc